SBIR/STTR Research Award

Development of Neural Protectants Against Organophosphorus Compound Toxicity

Award identifier e6538504786d46c0ad46b7f1d9eb1a6e0470f38487ed183875bba7800baea043Awarding agency Department of Defense · Army

Award amount

$69,948

Program and phase

SBIR · Phase I

Award year

2005

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Defense
Branch
Army
Recipient company
CFD Research Corporation
Proposal award date
2005-11-21
Contract end date
2006-05-20
UEI
V3KCP1HNFM33
Solicitation number
2005.2
Topic code
A05-130

Research abstract

We propose to develop a novel methodology to systematically develop therapeutic compounds for treatment of organophosphate (OP) induced neurotoxicity. A core hypothesis is that combined temporal measurement and computational analysis of cellular processes is needed to understand neurotoxicity and discover novel therapeutics/protectants. We propose a combination of experiment and computation whose goal is to elucidate a detailed mechanistic description of OP neurotoxicity including signalingpathways, metabolic effects and biochemical markers. Starting from current knowledge, we will construct a map of neural signaling/activity pathways and identify reporters of modulation by OP compounds. Using a modified microphysiometer, the dynamic metabolic and signaling changes in neurotypical PC12 cell will be probed. Network analysis tools will be used to analyze the experimental data, in order to validate/modify proposed pathways. Sensitivity analyses will be performed to identify control points for efficaceous intervention. In Phase II, with the aid of expanded measurements, intervention points and candidate therapeutic compounds will be identified. A multi-disciplinary partnership with expertise in (a) dynamic measurements of cellular toxicology/metabolism and (b) in-silico modeling of cellular signaling/metabolism and (c) neurotoxicology has been assembled. The research will be leveraged on ongoing efforts related to analysis of toxin exposure effects both at Vanderbilt and CFDRC.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

947 SBIR/STTR records share this UEI (1987–2026). Reported award amounts total $350,893,199. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Defense, National Aeronautics and Space Administration, Department of Health and Human Services, National Science Foundation, Department of Commerce, Department of Energy

Agency intelligence

Department of Defense

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.